AI Verdict
UNH has stronger fundamentals based on our AI analysis.
ABT vs UNH Fundamental Comparison
| Metric | ABT | UNH |
|---|---|---|
| Revenue | $11.2B | $111.7B |
| Net Income | $1.1B | $6.3B |
| Net Margin | 9.6% | 5.6% |
| ROE | 2.1% | 6.0% |
| ROA | 1.0% | 2.0% |
| Current Ratio | 1.39x | 0.80x |
| Debt/Equity | 0.57x | 0.69x |
| EPS | $0.61 | $6.90 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABT vs UNH: Frequently Asked Questions
Is ABT or UNH a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), UNH has stronger fundamentals. ABT is rated HOLD (74% confidence) while UNH is rated HOLD (77% confidence). This is not investment advice.
How does ABT compare to UNH fundamentally?
ABBOTT LABORATORIES has ROE of 2.1% vs UNITEDHEALTH GROUP INC's 6.0%. Net margins are 9.6% vs 5.6% respectively.
Which stock pays higher dividends, ABT or UNH?
ABT has a dividend yield of N/A or no dividend while UNH has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABT or UNH for long term?
For long-term investing, consider that ABT has HOLD rating with 74% confidence, while UNH has HOLD rating with 77% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABT vs UNH?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs UNH, the AI consensus favors UNH based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.